ARTES Biotechnology issued New Patent in Australia for VLP Technology
(PresseBox) - ARTES Biotechnology specialized in microbial cell line and process development as well as in technology transfer for pharmaceutical industry is pleased to announce the issuance of a new patent for their VLP platform. The patent will further strengthen the Metavax® platform of the company. In combination with the expression platform Hansenula Metavax® is a unique tool for the development of affordable, safe and effective vaccines.
?Our intellectual property strategy is to provide multiple layers of protection for our technology platform portfolio. We believe that this new patent will have additional reinforcement to our existing patent estate and for our service we offer clients for vaccine development,? said Dr. Melanie Piontek, Business Development Director of ARTES.
ARTES is a Germany-based biotechnology company specialized in recombinant protein production and process development from microbial expression systems. ARTES offers generation of optimized production cell lines in proprietary yeast expression systems based on Hansenula polymorpha. In addition to genetic engineering, the company provides fermentation and downstream process development, analytical assay development and production cell line characterization. ARTES operates worldwide from its 850 sqm S1 facilities in Langenfeld. The company focuses on contract R&D for red and white biotechnology products.
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
ARTES is a Germany-based biotechnology company specialized in recombinant protein production and process development from microbial expression systems. ARTES offers generation of optimized production cell lines in proprietary yeast expression systems based on Hansenula polymorpha. In addition to genetic engineering, the company provides fermentation and downstream process development, analytical assay development and production cell line characterization. ARTES operates worldwide from its 850 sqm S1 facilities in Langenfeld. The company focuses on contract R&D for red and white biotechnology products.
Datum: 22.04.2013 - 04:46 Uhr
Sprache: Deutsch
News-ID 1218491
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
Langenfeld
Phone:
Kategorie:
Handcrafts
Anmerkungen:
Diese Pressemitteilung wurde bisher 321 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"ARTES Biotechnology issued New Patent in Australia for VLP Technology
"
steht unter der journalistisch-redaktionellen Verantwortung von
ARTES Biotechnology GmbH (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
